Health Condition 1: K460- Unspecified abdominal hernia withobstruction, without gangrene Health Condition 2: S729- Unspecified fracture of femur Health Condition 3: S829- Unspecified fracture of lower leg
Conditions
Interventions
Intervention1: Inj Dexamethasone 8mg IV stat at time of premedication before spinal anaesthesia: Inj Dexamethasone 8mg IV stat at time of premedication before spinal anaesthesia
Sponsors
Kamal Nayan Joshi
Eligibility
Inclusion criteria
Inclusion criteria: 1) ASA Grade I & II 2) Superficial lower abdominal or lower limb surgery. 3) Surgeries planned under subarachnoid block 4) Patients with controlled blood sugar levels (FBS 5) Age between 30 years - 60 years. 6) Body mass index 7) Surgery lasting for 1-2 hours. 8) Hospital stay; for at least 48 hours.
Exclusion criteria
Exclusion criteria: 1) Patientâ??s refusal. 2) ASA Grade III & IV. 3) Surgeries planned under general anaesthesia. 4) Diabetic patients with blood sugar levels (FBS >130mg/dl). 5) Patients with bleeding diathesis. 6) Patients with electrolyte imbalances. 7) Patients with cardio-respiratory disease. 8) Patients with hepatorenal disease. 9) Patients allergic to the study drug or local anaesthetic. 10) Patients with history of treatment with steroids in last 3 months. 11) Any neuro-psychiatric illness. 12) Pregnancy 13) Obesity (body mass index >30 Kg/m2). 14) Day care surgeries.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To assess the perioperative blood sugar level changes in diabetic and non-diabetics after administration of single dose dexamethasoneTimepoint: 1. To assess the perioperative blood sugar level changes in diabetic and non-diabetics after administration of single dose dexamethasone | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the time of onset for hyperglycemia in diabetic and non diabetics (if it is there). 2. To assess the requirement of insulin & dextrose containing fluid. 3. To assess the hemodynamic parameter changes e.g. heart rate, non-invasive blood pressure, oxygen saturation, and electrocardiogram. 4. To assess for any adverse outcome during study period. Timepoint: Blood sugar levels will be measured hourly up to 3 hours from T0(time of injection dexamethasone) and labelled T1, T2 and T3; then 6 hourly from T0 till next 24 hours and 12 hourly for next 24 hours. | — |
Countries
India
Contacts
Public ContactDr Urmila Palaria
Government Medical College, Haldwani
Outcome results
None listed